Should You Go For This US Mid Cap Stock-QS

Acrobull Canada Advisory Inc.

November 04

2024

Name	Ticker	Sector/Industry	Market Cap	Risk Factor
QuantumScape Corporation	QS-NYSE	Consumer Cyclical	$2.624 Billion	Medium

QuantumScape Corporation, a research and development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. The company was founded in 2010 and is headquartered in San Jose, California.

Recent Highlights

Positive Points- QuantumScape Corp (NYSE:QS) has began generating tiny batches of its first B-sample cells, a significant step forward in its development process.

The QSE-5 cells have a measured energy density of 844 watt hours per liter and charge from 10% to 80% in just over 12 minutes, demonstrating superior performance characteristics.

The Raptor method, a revolutionary separator production technology, has been successfully applied, resulting in improved film quality, performance, and energy efficiency.

Third Quarter 2024 Financial Highlights

Capital expenditures in Q3 was $17.9 million, mostly for equipment purchases for low-volume QSE-5 prototype production and Cobra process preparation.

Full-Year Adjusted EBITDA Loss Guidance: Tightened to $280 million to $300 million, at the upper end of the previous range.

Higher legal fees and settlement accruals have pushed the adjusted EBITDA loss projection for 2024 to the upper limit of the previous range.

Capital Expenditure Guidance: Reduced to $60-75 million for 2024.

Stock Observation- The company stock earnings have been average, however long term aspects of the stock remain positive. The RSI level for the stock is at 42 which shows oversold conditions. Customers looking for mid to long term stock may choose to invest in it.

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

Considering all the factors and financials of the company Acrobull Canada Advisory Inc. maintains Customer Choose Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrovest only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrovest would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull Canada Advisory Inc. is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull Canada Advisory Inc. does not guarantee returns.

Acrobull Recommendation Based on Evaluation

Current Market Price	$5.12 USD
Acrobull Recommendation	Buy
Target Price	$5.85 USD
RSI Level	14 Day RSI 42
Total Shares Outstanding	457.81 Million
Shares held by Insiders Risk Factor Stop Loss	17.99% Medium 5%